메뉴 건너뛰기




Volumn 200, Issue 1, 2009, Pages 53-61

Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: A streptozotocin-induced model using wild-type and DPP4-deficient rats

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; DIPEPTIDYL PEPTIDASE IV; GLUCOSE; INSULIN; MESSENGER RNA; PROTEIN; STREPTOZOCIN; TRIACYLGLYCEROL; UREA;

EID: 67449155340     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0424     Document Type: Article
Times cited : (71)

References (37)
  • 3
    • 0036188070 scopus 로고    scopus 로고
    • Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs
    • Deacon CF, Wamberg S, Bie P, Hughes TE & Holst JJ 2002 Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs. Journal of Endocrinology 172 355-362.
    • (2002) Journal of Endocrinology , vol.172 , pp. 355-362
    • Deacon, C.F.1    Wamberg, S.2    Bie, P.3    Hughes, T.E.4    Holst, J.J.5
  • 5
    • 0026794360 scopus 로고
    • Biosynthesis and degradation of altered immature forms of intestinal dipeptidyl peptidase IV in a rat strain lacking the enzyme
    • Erickson RH, Suzuki Y, Sedlmayer A & Kim YS 1992 Biosynthesis and degradation of altered immature forms of intestinal dipeptidyl peptidase IV in a rat strain lacking the enzyme. Journal of Biological Chemistry 267 21623-21629.
    • (1992) Journal of Biological Chemistry , vol.267 , pp. 21623-21629
    • Erickson, R.H.1    Suzuki, Y.2    Sedlmayer, A.3    Kim, Y.S.4
  • 6
  • 7
    • 36849040001 scopus 로고    scopus 로고
    • Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice
    • Flock G, Baggio LL, Longuet C & Drucker DJ 2007 Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice. Diabetes 56 3006-3013.
    • (2007) Diabetes , vol.56 , pp. 3006-3013
    • Flock, G.1    Baggio, L.L.2    Longuet, C.3    Drucker, D.J.4
  • 8
    • 36148955109 scopus 로고    scopus 로고
    • Mechanisms of progression of chronic kidney disease
    • Fogo AB 2007 Mechanisms of progression of chronic kidney disease. Pediatric Nephrology 22 2011-2022.
    • (2007) Pediatric Nephrology , vol.22 , pp. 2011-2022
    • Fogo, A.B.1
  • 10
    • 6344241190 scopus 로고    scopus 로고
    • Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents
    • Green BD, Gault VA, O'Harte FPM & Flatt PR 2004a Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents. Current Pharmaceutical Design 10 3651-3662.
    • (2004) Current Pharmaceutical Design , vol.10 , pp. 3651-3662
    • Green, B.D.1    Gault, V.A.2    O'Harte, F.P.M.3    Flatt, P.R.4
  • 11
    • 1842530457 scopus 로고    scopus 로고
    • N-terminal His (7)-modification of glucagon-like peptide-1 (7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity
    • Green BD, Mooney MH, Gault VA, Irwin N, Bailey CJ, Harriott P, Greer B, O'Harte FPM & Flatt PR 2004b N-terminal His (7)-modification of glucagon-like peptide-1 (7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity. Journal of Endocrinology 180 379-388.
    • (2004) Journal of Endocrinology , vol.180 , pp. 379-388
    • Green, B.D.1    Mooney, M.H.2    Gault, V.A.3    Irwin, N.4    Bailey, C.J.5    Harriott, P.6    Greer, B.7    O'Harte, F.P.M.8    Flatt, P.R.9
  • 12
    • 33748531290 scopus 로고    scopus 로고
    • Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1
    • Green BD, Irwin N, Duffy NA, Gault VA, O'Harte FPM & Flatt PR 2006 Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. European Journal of Pharmacology 547 192-199.
    • (2006) European Journal of Pharmacology , vol.547 , pp. 192-199
    • Green, B.D.1    Irwin, N.2    Duffy, N.A.3    Gault, V.A.4    O'Harte, F.P.M.5    Flatt, P.R.6
  • 13
    • 31844443202 scopus 로고    scopus 로고
    • Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005
    • Holst JJ 2006 Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005. Diabetologia 49 253-260.
    • (2006) Diabetologia , vol.49 , pp. 253-260
    • Holst, J.J.1
  • 15
    • 45849115827 scopus 로고    scopus 로고
    • Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension
    • Jackson EK & Mi Z 2008 Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension 51 1637-1642.
    • (2008) Hypertension , vol.51 , pp. 1637-1642
    • Jackson, E.K.1    Mi, Z.2
  • 23
    • 0034090145 scopus 로고    scopus 로고
    • Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose
    • Meneilly GS, Demuth HU, McIntosh CHS & Pederson RA 2000 Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabetic Medicine 17 346-350.
    • (2000) Diabetic Medicine , vol.17 , pp. 346-350
    • Meneilly, G.S.1    Demuth, H.U.2    McIntosh, C.H.S.3    Pederson, R.A.4
  • 24
    • 0033619675 scopus 로고    scopus 로고
    • Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
    • Mentlein R 1999 Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regulatory Peptides 85 9-24.
    • (1999) Regulatory Peptides , vol.85 , pp. 9-24
    • Mentlein, R.1
  • 25
    • 45749095401 scopus 로고    scopus 로고
    • Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes
    • Mikhail N 2008 Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes. Expert Opinion on Investigational Drugs 17 845-853.
    • (2008) Expert Opinion on Investigational Drugs , vol.17 , pp. 845-853
    • Mikhail, N.1
  • 26
    • 0035985294 scopus 로고    scopus 로고
    • Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: Study using a Fischer 344 rat substrain deficient in its enzyme activity
    • Mitani H, Takimoto M, Hughes TE & Kimura M 2002 Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity. Japanese Journal of Pharmacology 88 442-450.
    • (2002) Japanese Journal of Pharmacology , vol.88 , pp. 442-450
    • Mitani, H.1    Takimoto, M.2    Hughes, T.E.3    Kimura, M.4
  • 28
    • 34548379454 scopus 로고    scopus 로고
    • Management of dyslipidemias in patients with diabetes and chronic kidney disease
    • Molitch ME 2006 Management of dyslipidemias in patients with diabetes and chronic kidney disease. Clinical Journal of the American Society of Nephrology 1 1090-1099.
    • (2006) Clinical Journal of the American Society of Nephrology , vol.1 , pp. 1090-1099
    • Molitch, M.E.1
  • 31
    • 33749064594 scopus 로고    scopus 로고
    • Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake
    • Ryskjaer J, Deacon CF, Carr RD, Krarup T, Madsbad S, Holst J & Vilsboll T 2006 Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. European Journal of Endocrinology 155 485-493.
    • (2006) European Journal of Endocrinology , vol.155 , pp. 485-493
    • Ryskjaer, J.1    Deacon, C.F.2    Carr, R.D.3    Krarup, T.4    Madsbad, S.5    Holst, J.6    Vilsboll, T.7
  • 32
    • 0026498840 scopus 로고
    • Biochemical and immunological properties of urinary angiotensinase A and dipeptidyla-minopeptidase IV - their use as markers in patients with renal cell injury
    • Scherberich JE, Wiemer J & Schoeppe W 1992 Biochemical and immunological properties of urinary angiotensinase A and dipeptidyla-minopeptidase IV - their use as markers in patients with renal cell injury. European Journal of Clinical Chemistry and Clinical Biochemistry 30 663-668.
    • (1992) European Journal of Clinical Chemistry and Clinical Biochemistry , vol.30 , pp. 663-668
    • Scherberich, J.E.1    Wiemer, J.2    Schoeppe, W.3
  • 33
    • 23844504364 scopus 로고    scopus 로고
    • Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
    • Srinivasan K, Viswanad B, Asrat L, Kaul CL & Ramarao P 2005 Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacological Research 52 313-320.
    • (2005) Pharmacological Research , vol.52 , pp. 313-320
    • Srinivasan, K.1    Viswanad, B.2    Asrat, L.3    Kaul, C.L.4    Ramarao, P.5
  • 34
    • 0026088951 scopus 로고
    • A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein - use as a liver-cell transplantation model
    • Thompson NL, Hixson DC, Callanan H, Panzica M, Flanagan D, Faris RA, Hong WJ, Hartel-Schenk S & Doyle D 1991 A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein - use as a liver-cell transplantation model. Biochemical Journal 273 497-502.
    • (1991) Biochemical Journal , vol.273 , pp. 497-502
    • Thompson, N.L.1    Hixson, D.C.2    Callanan, H.3    Panzica, M.4    Flanagan, D.5    Faris, R.A.6    Hong, W.J.7    Hartel-Schenk, S.8    Doyle, D.9
  • 36
    • 0037205175 scopus 로고    scopus 로고
    • Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats
    • Yasuda N, Nagakura T, Yamazaki K, Inoue T & Tanaka I 2002 Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats. Life Sciences 71 227-238.
    • (2002) Life Sciences , vol.71 , pp. 227-238
    • Yasuda, N.1    Nagakura, T.2    Yamazaki, K.3    Inoue, T.4    Tanaka, I.5
  • 37
    • 0347064086 scopus 로고    scopus 로고
    • Overexpression of repressive cAMP response element modulators in high glucose and fatty acid-treated rat islets - a common mechanism for glucose toxicity and lipotoxicity?
    • Zhou YP, Marlen K, Palma JF, Schweitzer A, Reilly L, Gregoire FM, Xu GG, Blume JE & Johnson JD 2003 Overexpression of repressive cAMP response element modulators in high glucose and fatty acid-treated rat islets - a common mechanism for glucose toxicity and lipotoxicity? Journal of Biological Chemistry 278 51316-51323.
    • (2003) Journal of Biological Chemistry , vol.278 , pp. 51316-51323
    • Zhou, Y.P.1    Marlen, K.2    Palma, J.F.3    Schweitzer, A.4    Reilly, L.5    Gregoire, F.M.6    Xu, G.G.7    Blume, J.E.8    Johnson, J.D.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.